Related Experiment Video
Updated: May 5, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Designing type II topoisomerase inhibitors: A molecular modeling approach
Juan J Perez, Cecylia S Lupala, Patricia Gomez-Gutierrez1
1Department of Chemical Engineering. Universitat Politecnica de Catalunya, ETSEIB. Av. Diagonal, 647; 08028 Barcelona, Spain. juan.jesus.perez@upc.edu.
Abstract:
Nosocomial infections are produced by pathogens with the ability to persist in hospital environments and with the propensity to develop resistance to diverse antimicrobials. In order to tackle resistance, it has been pointed as good strategy to select resilient drug targets that are evolutionally constrained to design drugs less susceptible to develop resistance. Molecular modeling can help to fulfill this goal by providing a rationalization of the observed resistance at the molecular level and, suggesting modifications on existing drugs or in the design of new ones to overcome the problem. The present report focus on type II topoisomerases, a clinical validated target for antibacterials and describe diverse modes of intervention including, inhibition of their ATPase function, stabilization of the cleavage complex or prevention of DNA strand hydrolysis. Moreover, the origin of resistance is also rationalized on the base of ligand-target interactions. Finally, efforts are described to circumvent the effect of non-susceptible strains by the design of new drugs based on existing ones, like the case of diones that act through the same mechanism as quinolones or the newly released quinole-carbonitrile derivatives that inhibit type II topoisomerases through a new mechanism.
Insights
To combat antimicrobial resistance, researchers are developing new drugs targeting resilient bacterial enzymes like type II topoisomerases. Molecular modeling aids in designing drugs less prone to resistance, ensuring effective treatments for nosocomial infections.
Area of Science:
- Microbiology
- Drug Discovery
- Computational Chemistry
Background:
- Nosocomial infections are driven by persistent, drug-resistant pathogens.
- Antimicrobial resistance necessitates strategies like targeting evolutionarily constrained bacterial enzymes.
- Molecular modeling offers insights into resistance mechanisms and drug design.
Purpose of the Study:
- To explore type II topoisomerases as antibacterial targets.
- To rationalize drug resistance at the molecular level.
- To guide the design of novel antibacterial agents overcoming resistance.
Main Methods:
- Focus on type II topoisomerases as validated antibacterial targets.
- Utilizing molecular modeling to analyze ligand-target interactions and resistance origins.
- Investigating diverse inhibition strategies: ATPase function, cleavage complex stabilization, DNA hydrolysis prevention.
Main Results:
- Identified type II topoisomerases as key targets for antibacterial drug development.
- Rationalized the molecular basis of antimicrobial resistance.
- Proposed strategies for circumventing resistance, including diones and quinole-carbonitrile derivatives.
Conclusions:
- Targeting type II topoisomerases is a promising strategy against resistant nosocomial pathogens.
- Molecular modeling is crucial for designing next-generation antibiotics.
- Novel drug designs, like diones and quinole-carbonitriles, offer new mechanisms to combat resistance.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Inhibitors of Bacterial DNA Synthesis
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Molecular Models